Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Institut du Cancer de Montpellier - Val d'Aurelle
after registration, particpants have as treatment "combination extended tumorectomy with axillary dissection (sentinel lymph node) in addition to 20 Gy of per-operative partial irradiation at the tumor site.
follow up after this treatment during 5 years
Age
60–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women 60 years of age or older,
Histologically proven invasive ductal breast cancer or of a histologically favorable sub-type (mucinous, tubular or colloid),
-. Unifocal tumor,
T1 (diameter ≤ 20 mm),
N0 (pN0 or pNi+),
M0,
Gland exeresis margins ≥ 2 mm,
Estrogen receptor positive,
Information and non-opposition of the patient.
You may not be if
. Inflammatory breast cancer,
Associated peri-tumoral lymphatic emboli
Associated extensive intra-ductal component
Invasive lobular carcinoma
Pure ductal carcinoma in situ,
Sarcoma or lymphoma-type non-epithelial tumor
Synchronous bilateral breast cancer,
Any prior neo-adjuvant treatment: radiotherapy, chemotherapy, hormone therapy
Clareo Health | Observational Study of Intra-operative Partial Irradiation of Invasive Ductal Breast Carcinomas With a Good Prognosis
